Trial Profile
A Study to Investigate the Influence of MK0859 [anacetrapib] on Blood Pressure
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Anacetrapib (Primary)
- Indications Atherosclerosis; Hypercholesterolaemia; Hyperlipidaemia
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme Corp.
- 19 Dec 2007 New trial record.